Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on April 28, 2025
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
GlobeNewswire
·
April 28, 2025
WEST ORANGE, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0 …
EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Partnership and First-Ever 5K Sponsorship
EIN Presswire
·
April 28, 2025
From strategic partnership to global employee action, EBC joins the global movement to end malaria for good. DC, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As the world marks World Malaria Day 2025 under the theme “Malaria Ends With Us: …
Capital Bancorp, Inc. Announces Strong First Quarter Results and Successful IFH Conversion; Continued Strong Organic Loan and Deposit Growth; NIM and Fee Income Drives Robust Returns
GlobeNewswire
·
April 28, 2025
First Quarter 2025 Highlights Net Income of $13.9 million, or $0.82 per share, and return on average assets ("ROA") of 1.75% Core net income(1) of $14.9 million, or $0.88 per share, and core ROA(1) of 1.87% Book value per common share of $22.19 at March 31 …
Digital Asset Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
GlobeNewswire
·
April 28, 2025
PRINCETON, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- Digital Asset Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global …
Flexi-View Lending Closes $13.2 Million Acquisition Loan for Multi-Family Property in Milwaukee, WI
GlobeNewswire
·
April 28, 2025
LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- Flexi-View Lending is proud to announce the successful closing of a $13.2 million acquisition loan for a premier multi-family property located in Milwaukee, Wisconsin. The deal was closed in an impressive 14- …
PDD Holdings Files Annual Report on Form 20-F for Fiscal Year 2024
GlobeNewswire
·
April 28, 2025
DUBLIN and SHANGHAI, April 28, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and …
SJW Group Announces First Quarter 2025 Financial Results
GlobeNewswire
·
April 28, 2025
First quarter 2025 reported diluted EPS of $0.49, a 36% increase in diluted EPS over the prior year, and adjusted diluted EPS of $0.50, a 39% increase in adjusted diluted EPS over the prior year First quarter 2025 infrastructure investment was $78.2 …
Real Asset Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
GlobeNewswire
·
April 28, 2025
PRINCETON, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- Real Asset Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global …
Brown & Brown, Inc. announces first quarter 2025 results, including total revenues of $1.4 billion, an increase of 11.6%; Organic Revenue growth of 6.5%; diluted net income per share of $1.15; Diluted Net Income Per Share - Adjusted of $1.29; and a…
GlobeNewswire
·
April 28, 2025
DAYTONA BEACH, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- Brown …
AppLovin Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 5, 2025 Deadline to file Lead Plaintiff Motion.
GlobeNewswire
·
April 28, 2025
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AppLovin Corporation ("AppLovin" or the "Company") (NASDAQ: APP) investors of a class …
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) …
GROUNDBREAKING NON-INVASIVE THERAPY TREATING FIRST RESPONDERS AND VETERANS, SCORES BIG WITH PROFESSIONAL ATHLETES
EIN Presswire
·
April 28, 2025
VECTTOR™ Technology, a groundbreaking non-invasive therapy designed to treat chronic pain and neurological disorders, is scoring big with professional athletes. WIMBERLEY, TX, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- VECTTOR™ Technology, a …
Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
GlobeNewswire
·
April 28, 2025
Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting Additional poster presentation to feature scalability …
Manhattan Associates, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 28, 2025 Deadline to file Lead Plaintiff Motion.
GlobeNewswire
·
April 28, 2025
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Manhattan Associates, Inc. ("Manhattan Associates" or the "Company") (NASDAQ: MANH) …
BLZE Announcement: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that …
Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the first quarter ended March 31, 2025 on Monday, May 12, 2025 before the market opens. The company will hold …
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annual …